Abstract:
The present invention relates to an extract of processed Panax genus plant obtained by maillard browning reaction of Panax genus extract with at least one amino acid selected from the group consisting of valine, arginine, and alanine at 100-130°C for 0.5-12 hours; a method for manufacturing the same; and a composition comprising the extract for anti-cancer, neuroprotection, inhibition of platelet aggregation, antioxidant, anti-inflammatory, renal protection, or anti-fatigue. The present invention also provides an extract of processed Panax genus plant obtained by maillard browning reaction of Panax genus extrac with at least one amino acid selected from the group consisting of leucine and glutamine at 100-130°C for 0.1-12 hours; a method for manufacturing the same; and an anti-cancer composition comprising the extract.
Abstract:
The present invention provides Panax spp. plant extract which includes 90% or more of Rg3, Rk1, and Rg5 based on the weight of ginsenoside Rb1, Rc, Rb2, Rd, Rg3, Rk1 and Rg5 obtained by making microwave reaction with Panax spp. plant or the extract, a method for preparing the same, a pharmaceutical composition for improving anti-cancer agent side effects selected from immune degradation and anti-cancer agent tolerance, antioxidant, anti-cancer, antiinflammatory, brain function or cognitive skills, blood vessel relaxation, platelet coagulation suppression, dermatitis, or psoriasis and a composition for health supplement. [Reference numerals] (AA) Voltage (mV);(BB) Time (minute)
Abstract:
PURPOSE: A composition for preventing, treating, or alleviating peroxisome proliferator-activated receptor (PPAR) action regulatory diseases is provided to promote PPAR activation and to prevent, treat, or alleviate the diseases including obesity, metabolic diseases, and cardiovascular diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating PPAR action regulator diseases selected among diabetes, obesity, hyperinsulinemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, artery scleroma, and combination thereof contains a compound of chemical formula 1 or 2, or a pharmaceutically acceptable salt or a solvate thereof. A composition for health functional foods for preventing or treating the diseases contains the compound, the pharmaceutically acceptable salt, or the solvate.
Abstract:
PURPOSE: A therapeutic composition is provided to be able to be effectively used in prevention, alleviation or treatment of kidney diseases as the Panax species plant extract or the product of the Maillard type browning reaction with glucose amino acid have an excellent removal ability of active oxygen, and remarkably excellent activation to suppress damage of kidney epithelial cell due to the oxidative stress. CONSTITUTION: A pharmaceutical composition for prevention or treatment of kidney diseases comprises ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. A composition for health functional food for prevention or alleviation of kidney diseases includes ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. The Panax species plant is Korean ginseng, Panax quinquefolius, Panax notoginseng, Japanse seng, Panax trifolium, Himalayan ginseng, Panax vietnamensis, their cultured root, or their combination. [Reference numerals] (AA) Ginsenoside Re; (BB) Ginsenoside Rg_2; (CC) Dehydration reaction; (DD) Ginsenoside Rg_6; (EE) Ginsenoside F_4; (FF) Separated glucose + Glycine; (GG) Maillard browning reaction
Abstract:
PURPOSE: A Panax species plant extract having the increased content of ginsenoside Rg5 and Rk1 by microwave irradiation, a manufacturing method thereof, and a composition containing the processed Panax species plant extract are provided to enhance an effect of Rg5 and Rk1 compared to an extract by simple thermal-processing. CONSTITUTION: A manufacturing method of a Panax species plant extract comprises: a step of irradiating Panax species plants or an extract thereof with microwaves. The Panax species plant or the extract contains more than 90% of Rg3, Rk1, and Rg5 to the weight of ginsenoside Rb1, Rc, Rb2, Rd, Rg3, Rk1 and Rg5. The microwave irradiation is performed at 150-190 deg. C for 30-90 minutes while pressurizing. The microwave irradiation is performed under 2-100 atmospheric pressure. The Panax species plant extract has a ratio of ginsenoside (Rg5+Rk1)/(Rg3) of 2 or greater. [Reference numerals] (AA) Voltage(mv); (BB) Time(minutes)
Abstract:
본 발명은 다중약물내성 암세포에 유용한 항암제에 관한 것으로서, 구체적으로 상기 3-(2-벤족사졸릴)-7-(디에틸아미노)쿠마린[3-(2-Benzoxazolyl)- 7-(diethylamino)Coumarin]을 유효성분으로 함유하는 기존 항암제에 대해 다중약물내성을 나타내는 암세포에 대한 우수한 사멸효과를 제공하는 조성물에 관한 것이다. 본 발명의 조성물은 항암제에 내성을 나타내는 다중약물내성(Multidrug resistance, MDR) 세포에서 보이는 항암제내성을 극복할 수 있어서 정상암세포는 물론 MDR을 나타내는 세포에서도 항암효과가 있으므로, 약학적으로 유용한 항암제로 사용될 수 있다. 3-(2-벤족사졸릴)-7-(디에틸아미노)쿠마린, 다중약물내성
Abstract:
A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities is provided to show wrinkle and elasticity improvement by the Chamaenerion angustifolium extracts having effects of inhibiting type I collagenase and AP-1. A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities comprises Chamaenerion angustifolium extract obtained by adding water and alcohol or a mixed solvent thereof. The Chamaenerion angustifolium extract inhibits inflammation and improves skin elasticity. The composition has a formulation of external skin application. The composition represents cosmetics or health foods. The Chamaenerion angustifolium extract is an active ingredient in the composition.
Abstract:
A composition containing Ortilia secunda extracts is provided to show wrinkle and elasticity improvement by the Ortilia secunda extracts having effects of inhibiting type I collagenase and AP-1 and increasing generation of collagen while suppressing decomposition of the collagen. A composition for wrinkle improvement comprises Ortilia secunda extracts obtained by adding water and C1-C4 low alcohol such as ethanol and methanol or mixed solvents thereof. The Ortilia secunda extracts are active ingredients in the composition for wrinkle improvement. The Ortilia secunda extracts eliminate radicals. The composition has a formulation of external skin application. The composition for wrinkle improvement represents antioxidant.
Abstract:
본 발명은 드라코세팔룸 포에티둠 추출물, 고두자 추출물 또는 이의 분획물을 포함하는 항균용 조성물에 관한 것으로, 보다 상세하게는 드라코세팔룸 포에티둠 추출물, 고두자 추출물 및 이의 분획물은 피부표면의 세균 및 진균, 식품의 부패와 식중독을 일으키는 원인균 및 충치균뿐 아니라 항생제 내성균에 대해서도 항균활성을 가지고 있으며, 드라코세팔룸 포에티둠 추출물은 그의 휘발성분에 의해서도 항균활성을 나타내므로 피부표면을 세정 및 정균·살균하고, 식품의 부패를 막고 식중독을 예방하며, 구강 내 질환 및 충치를 예방하는 항균용 조성물뿐만 아니라 공기청정용품의 필터 등에 천연 항균제로서 부작용없이 유용하게 사용할 수 있다.
Abstract:
An extract of Dracocephalum foetidum and an extract of Sophora alopecuroides are provided to be used as an antibacterial composition for washing and sterilizing the skin surface, prevent the decay and the poisoning of the food, and periodontal diseases, and be used as a natural antibacterial agent for a filter of an air purifying product by having antibacterial activity on bacteria and fungi of skin surface, bacteria causing decay of foods and food-poisoning, Streptococcus Mutans and antibiotics resistant bacteria. An antibacterial composition comprises an extract of Dracocephalum foetidum which is a refined oil ingredient of the Dracocephalum foetidum or an extract of Sophora alopecuroides which is prepared by using a solvent such as water, alcohol, hexane, methylene chloride, ethyl acetate and a mixture thereof.